22 mars: Berlin se dit proche d'un accord avec Airbus sur l'A350
22 mars: France - Décollecte de E0,28 md en février du Livret A et du LDD
22/03/2010 15:30:00

Next Generation Portable Water Quality Analyzer Introduced By SDIX

SDIX (Nasdaq: SDIX), a leading provider of biotechnology-based

products and services for a broad range of life science, biotech,

diagnostic, and food safety applications, today announced DeltaTox®

II, its next generation portable water quality field testing analyzer.

Designed for on-site screening at remote locations as well as for

laboratory-based water testing, the DeltaTox II analyzer replaces SDIX’s

existing DeltaTox devices, delivering test results within five minutes.

With both chemical and bio-contamination detection in one analyzer,

DeltaTox II provides rapid screening and characterization of potable

water and waste water as well as industrial and environmental water

samples.

SDIX water quality products like DeltaTox II are designed to reduce the

time and cost to test water while also providing reliable and accurate

results for informed decision making. Some customers have realized up to

50% total cost reduction versus competing alternatives.

DeltaTox II features include:

  • Fast results – rapid screening, within five minutes in the field

  • Detects both toxins and bio-contamination in one device – over 2,700

    harmful substances and chemical compounds have been documented to date

  • Improved ease-of-use – An intuitive, menu-driven user interface with

    over 50% larger backlit display screen provides more information than

    before

  • Increased reliability – No electromechanical parts, 1 year full

    warranty

  • Portable and durable – Small, rugged, lightweight (2.2 lbs) device

    made from high-strength engineering polymer, rechargeable lithium ion

    battery

SDIX water quality testing instruments are being used by over 70% of the

largest water utilities in the USA as well as wastewater treatment

facilities, industrial water treatment systems, and environmental and

eco-toxicological research organizations. These products are also

extensively used outside the U.S., in Asia, Europe and other regions

around the globe. DeltaTox II is expected to be available for sale the

second quarter of 2010. Pricing will be announced at that time.

Commenting, Michael Jones, SDIX Water Quality Market Manager, said,

“With the new DeltaTox II, customers will have more rapid, accurate,

reliable, and cost-effective results than ever, enabling them to feel

secure about their water consumption or use. Moreover, we feel it is

important to be introducing a next generation water toxicity analyzer at

a time when the global need for remote location testing is increasing

dramatically. DeltaTox II can also help us expand into new regions where

on-site testing is critical to ensure a safe water supply to the local

population.”

DeltaTox II is a member of SDIX’s family of water quality testing

products. For more information, call 800-544-8881, visit www.sdix.com

or www.sdix.com/deltatox.

About SDIX

SDIX is a biotechnology company, expert at creating advantage by

providing a broad range of quality, innovative and effective

immuno-solutions to the Pharmaceutical, Biotechnology, Diagnostics, and

Food Safety markets. For 20 years, SDIX has developed antibodies which

advance its customers’ immuno-based work – reducing time, labor, and

costs while increasing accuracy and reliability of results.

SDIX offers a full suite of integrated immuno-solution capabilities

including assay design, development, and production. In life science

markets, SDIX capabilities are being used to help discover the

mechanisms of disease, facilitate the development of new drugs, and

provide mechanisms for rapid diagnosis. For more information, visit www.sdix.com.

This news release may contain forward-looking statements reflecting

SDIX's current expectations. When used in this press release, words like

“anticipate”, “could”, “enable”, “estimate”, “intend”, “expect”,

“believe”, “potential”, “will”, “should”, “project”, “plan” and similar

expressions as they relate to SDIX are intended to identify said

forward-looking statements. Investors are cautioned that all

forward-looking statements involve risks and uncertainties, which may

cause actual results to differ from those anticipated by SDIX at this

time. Such risks and uncertainties include, without limitation, changes

in demand for products, the application of our technologies to various

uses, delays in product development, delays in market acceptance of new

products, retention of customers and employees, adequate supply of raw

materials, inability to obtain or delays in obtaining fourth party,

including AOAC, or required government approvals, the ability to meet

increased market demand, competition, protection of intellectual

property, non-infringement of intellectual property, seasonality, and

other factors more fully described in SDIX's public filings with the

U.S. Securities and Exchange Commission.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6220106&lang=en

SDIX

Michael Jones

Market Manager, Water Quality

302-456-6789

mjones@sdix.com

22 mars: Berlin se dit proche d'un accord avec Airbus sur l'A350
22 mars: France - Décollecte de E0,28 md en février du Livret A et du LDD

Envoyer un commentaire

Related debate

  • 1 semaine
  • 1 mois
  • 1 an
19 août
VELO
Som overskriften så pænt fortæller, så vil jeg gerne have Match tilbage. Og fordi at jeg tør og skri..
29
12:16
BIOPOR
  Bioporto kom med Q2 regnskab fredag den 8/8, og holdt efterfølgende en investor præsentation. Jeg ..
25
19 août
VELO
Jeg har rejst en del denne sommer, me har ind imellem lige været inde for at se, om der er nyt. Sene..
23
17 août
 
Janemlig, jeg synes det er forstemmende man kan leve med fri adgang til alle informationer og så all..
17
14 août
 
Normal 0 21 false false false NO-BOK X-NONE X-NONE ..
17
18 août
 
  Financial Times har i dag bragt en ganske interessant artikel. Federal Reserve har d. 5. August i ..
15
16 août
 
Jeg sagde at jeg var blevet fartblind på aktiemarkedet i sidste uge. Jeg fik meget ud af de svar som..
13
13 août
OMXC20
Da jeg havde tabt 40% på 2 måneder. Hele tæppet gled væk under mig inden jeg kunne nå at reagere. Fr..
13
17 août
FING-B
Nu læste jeg det igennem af generel interesse i biometri. Det svenske indlæg handler om udfordringer..
12
16 août
I:SP500
  En analyse vedr. Europas manglende vækst.   I en tidligere tråd advokerede jeg for, at vi (global..
12

Actualité la plus lue

  • 24 heures
  • 48 heures
  • 1 semaine
1
SANOFI : La FDA approuve CerdelgaTM (eliglustat) de Genzyme en gélules
2
ATOS : Evolution de la gouvernance du groupe Bull
3
Crédit Agricole Brie Picardie : déclaration hebdo transactions sur actions propres
4
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2014
5
BIC : Rachats actions - Juillet 2014
Euroinvestor dans le monde entier: Euroinvestor.dk | Euroinvestor.se | Euroinvestor.no | Euroinvestor.com | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Droit d'auteur Euroinvestor A/S 2014   Mentions légales et conditions d'utilisation
Information sur les cours fournies par Interactive Data.
Les données sont différées de 15 à 20 minutes selon les accords avec les différentes bourses internationales.
 
mercredi 20 août 2014 18:31:52
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140819.1 - EUROWEB4 - 2014-08-20 18:31:52 - 2014-08-20 18:31:52 - 4 - Website: OKAY